What development phase is Eraldin in?

Eraldin is FDA-approved (marketed).

What is the generic name of Eraldin?

PRACTOLOL is the generic (nonproprietary) name of Eraldin.

Last reviewed 2026-04-20 · How we verify

Eraldin (PRACTOLOL)

FDA-approved withdrawn Small molecule Quality 15/100

At a glance

Generic name	PRACTOLOL
Drug class	practolol
Target	Beta-1 adrenergic receptor, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Eraldin CI brief — competitive landscape report
Eraldin updates RSS · CI watch RSS